Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1733 |
|---|---|
| Identifier | NCT04590508 |
| Trial Title | A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Xanthohumol|OTHER: Placebo |
Participant Information
| Sponsor | National University of Natural Medicine |
|---|---|
| City | Portland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-10-01 |
|---|---|
| Primary Completion Date | 2024-08-22 |
| Completion Date | 2025-07-30 |